|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
12 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | Arthur Holden: banking on our genes |
Owens, Joanna |
2003 |
2 | 3 |
p. 78-81 4 p. |
article |
|
| 2 | Chemogenomics identifies fusion tyrosine kinase |
Habeck, Martina |
2003 |
2 | 3 |
p. 75-76 2 p. |
article |
|
| 3 | Haemozoin (malaria pigment): a unique crystalline drug target |
Egan, Timothy J. |
2003 |
2 | 3 |
p. 115-124 10 p. |
article |
|
| 4 | It's a knockout! |
Howard, JulieP. |
2003 |
2 | 3 |
p. 76-77 2 p. |
article |
|
| 5 | One step closer to specific cancer drugs? |
Sutherland, Stephani |
2003 |
2 | 3 |
p. 73-74 2 p. |
article |
|
| 6 | Patent prosecution in proteomics |
Chan, Keala |
2003 |
2 | 3 |
p. 81-84 4 p. |
article |
|
| 7 | Potassium channel target for breast cancer |
Foubister, Vida |
2003 |
2 | 3 |
p. 72-73 2 p. |
article |
|
| 8 | Protein structure: discovering selective protein kinase inhibitors |
Buchanan, Sean G. |
2003 |
2 | 3 |
p. 101-108 8 p. |
article |
|
| 9 | Proteomic approaches for generating comprehensive protein interaction maps |
Auerbach, Daniel |
2003 |
2 | 3 |
p. 85-92 8 p. |
article |
|
| 10 | siRNA as a tool for streamlining functional genomic studies |
Boese, Queta F. |
2003 |
2 | 3 |
p. 93-100 8 p. |
article |
|
| 11 | Target validation requirements in the pharmaceutical industry |
Winkler, Hans |
2003 |
2 | 3 |
p. 69-71 3 p. |
article |
|
| 12 | The importance of alternative splicing in the drug discovery process |
Levanon, Erez Y. |
2003 |
2 | 3 |
p. 109-114 6 p. |
article |
12 results found